News
News Archiv
-
Post date:27. October 2020 - 11:48
Our second retreat took place from 19.10.2020 to 20.10.2020. Due to the Covid crisis we run it as a fully virtual event with 80+ participants. The retreat included presentations of the ongoing projects as well as new project proposals. Despite the virtual setup we had very intensive and lively discussions.
-
Post date:26. October 2020 - 16:20
Maria Robles, Principal investigator of P11, was awarded the first prize of the “Proteomics Highlight of the Year” for her 2019 Science publication Sleep-wake cycles drive daily dynamics of synaptic phosphorylation.
-
Post date:14. October 2020 - 11:44
The teams of Mauricio Berriel Diaz (Principal investigator of P09) and Maria Rohm performed lipidomics on plasma of cachexia models and cancer patients and identified specific lipid species as a hallmark of cancer-associated weight loss.
-
Post date:5. October 2020 - 11:00
We have found that reprogramming of cancer-associated fibroblasts by Prrx1 deletion restrains pancreatic cancer progression and metastasis. These data highlight the possibilities of new treatment strategies through the conversion of tumor-promoting CAFs into tumor-restraining CAFs.
-
Post date:28. July 2020 - 14:04
The Else Kröner-Fresenius-Foundation has selected Principal investigator PD Dr. Ihsan Ekin Demir, Ph.D (Project P07) for one of the Else Kröner Clinician Scientist Professorships 2019.
-
Post date:6. July 2020 - 10:46
A multidisciplinary team led by SFB 1321 Principal investigator PD Dr. Max Reichert (P12, S01) discovers that cell-free DNA shed by pancreatic cancer patient-derived organoids allow accelerated implementation organoid technology in personalized oncology.